Position in SIGA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$220,420
-$105,346 QoQ
Shares Held
41,200
-22.7% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vestcor Inc holds $18,826,284 across 17 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
13,447 | $7,285,988 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
10,439 | $1,759,389 | |
| 3 | ALKS |
Alkermes plc.
|
30,230 | $1,584,052 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
34,263 | $1,405,810 | |
| 5 | VTRS |
Viatris Inc
|
87,478 | $1,389,150 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
71,721 | $1,241,490 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
13,123 | $839,215 | |
| 8 | ZTS |
Zoetis Inc.
|
11,578 | $831,995 |
All Filings in SIGA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $220,420 | 41,200 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $325,766 | 53,317 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $133,617 | 14,603 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $5,107 | 932 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $289,543 | 48,177 | Shares | Sole | 2025-02-10 | |
| 2023-03-31 | $22,994 | 3,999 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $29,432 | 3,999 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $41,189 | 3,999 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||